Disclaimer: This article is for informational purposes only. It is not medical advice. Weight management concerns should be ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Carefully timed bursts of carbon dioxide are emerging as a surprising tool to help the brain wash away toxic proteins linked to Parkinson’s disease. Instead of a new pill or implant, researchers are ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

In a pine forest on Michigan’s Upper Peninsula, the only active nickel mine in the US is nearing the end of its life. At a ...

Debated is the genesis of the first direct-to-consumer (DTC) drug concept in the U.S. Going back to at least 2011, Pfizer’s “unorthodox” Diplomat Specialty Pharmacy partnership aimed to launch Lipitor ...

Certain times—and workouts—are better than others.

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Andy Smith is a Certified Financial ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Thomas J Catalano is a CFP and Registered Investment Adviser with the ...